HR2111-119

In Committee

To amend the Federal Food, Drug, and Cosmetic Act to exempt the premium cigar industry from certain regulations.

119th Congress Introduced Mar 14, 2025

Summary

What This Bill Does

This bill exempts premium cigars from certain FDA tobacco regulation by changing the statutory definition of tobacco product. Findings state that premium cigars are a small share of the cigar market, many manufacturers are family-owned small businesses, sales typically occur in age-controlled settings such as cigar shops and cigar bars, and a 2022 National Academies report identified premium cigar use patterns including low youth use. The operative provision says the term tobacco product does not mean a premium cigar. A premium cigar must be wrapped in whole tobacco leaf, use a 100 percent leaf tobacco binder, contain at least 50 percent long-filler tobacco by filler weight, be handmade or hand rolled without machinery other than simple tools, have no filter or non-tobacco mouthpiece, have no characterizing flavor other than tobacco, contain only tobacco, water, and vegetable gum, and weigh more than six pounds per thousand units.

Who Benefits and How

Premium cigar manufacturers benefit because qualifying products would no longer be treated as tobacco products under the federal definition. Family-owned cigar businesses benefit from reduced FDA regulatory exposure for hand-rolled premium cigars. Cigar specialty shops benefit if premium cigar sales face fewer federal tobacco-product restrictions. Adult premium cigar consumers benefit from potentially broader availability of qualifying products.

Who Bears the Burden and How

FDA tobacco regulators lose authority over cigars meeting the premium cigar definition. Public health advocates focused on tobacco regulation lose federal coverage for a category of cigar products. Cigar manufacturers must ensure products meet the whole-leaf, long-filler, handmade, no-filter, no-flavor, tobacco-only, and weight criteria. Retailers must distinguish qualifying premium cigars from other cigar products that remain regulated.

Key Provisions

  • Excludes premium cigars from the FDCA tobacco product definition.
  • Requires whole tobacco leaf wrapping, 100 percent leaf tobacco binder, and at least 50 percent long filler tobacco.
  • Requires handmade or hand-rolled production with no filter, non-tobacco mouthpiece, or characterizing flavor other than tobacco.
  • Requires only tobacco, water, and vegetable gum ingredients and weight above six pounds per thousand units.

Evidence Chain:

This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.

At a Glance

What This Bill Does

Excludes premium cigars from the Federal Food, Drug, and Cosmetic Act definition of tobacco product when they meet specified hand-rolled, whole-leaf, long-filler, no-filter, tobacco-only, no-characterizing-flavor, and weight criteria.

Key Policy Areas

Tobacco, FDA, Small Business

Primary Purpose

Excludes premium cigars from the Federal Food, Drug, and Cosmetic Act definition of tobacco product when they meet specified hand-rolled, whole-leaf, long-filler, no-filter, tobacco-only, no-characterizing-flavor, and weight criteria.

Policy Domains

Tobacco FDA Small Business

Resolution provisions

Identified Gains
  • Premium cigar manufacturers
  • Family-owned cigar businesses
  • Cigar specialty shops
  • Adult premium cigar consumers
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: ih
Cigar specialty shops: ,
Premium cigar manufacturers: ,
Adult premium cigar consumers: ,
Family-owned cigar businesses: ,
Identified Costs
  • Food and Drug Administration
  • Public health advocates
  • Cigar manufacturers
  • Tobacco retailers
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: ih
Tobacco retailers: ,
Cigar manufacturers: ,
Public health advocates: ,
Food and Drug Administration: ,

Legislative Progress

In Committee
Introduced Committee Passed
Mar 14, 2025

Mr. Donalds (for himself, Mr. Langworthy, Ms. Titus, and Mr. …

Mar 14, 2025

Referred to the House Committee on Energy and Commerce.

Mar 14, 2025

Introduced in House

Stakeholder Effects

cui bono?

How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.

Retail
4 mentions across 2 clauses
+2 positive -2 negative

Cigar specialty shops, Tobacco retailers

Positive-direction: Cigar specialty shops

Negative-direction: Tobacco retailers

Manufacturing
2 mentions across 2 clauses
+2 positive

Premium cigar manufacturers

Small Business
2 mentions across 2 clauses
+2 positive

Family-owned cigar businesses

Consumer Goods
2 mentions across 2 clauses
?2 uncertain

Adult premium cigar consumers

Government
2 mentions across 2 clauses
?2 uncertain

Food and Drug Administration

Health Care
2 mentions across 2 clauses
?2 uncertain

Public health advocates

2/2
sections analyzed
Full impact breakdown

Bill Structure & Actor Mappings

Who is "The Secretary" in each section?

Domains
Tobacco FDA Small Business

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology